Hematopoietic Stem Cell TransplantationB-Lymphocyte SubsetsStem Cell TransplantationTransplantation, HomologousTransplantation ConditioningPeripheral Blood Stem Cell TransplantationGraft vs Host DiseaseMultiple MyelomaMelphalanStem CellsTreatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsHematologic NeoplasmsCombined Modality TherapyRemission InductionMyeloablative AgonistsBone Marrow TransplantationRecurrenceSalvage TherapyDisease-Free SurvivalTransplantation ChimeraBusulfanCyclophosphamideSurvival RateHodgkin DiseaseGraft SurvivalTissue DonorsSurvival AnalysisHematopoietic Stem Cell MobilizationRetrospective StudiesCytarabineEtoposideWhole-Body IrradiationLymphoma, Non-HodgkinHematopoietic Stem CellsGraft vs Leukemia EffectVidarabineLiver TransplantationLeukemia, Myeloid, AcuteCarmustineGraft vs Tumor EffectHistocompatibility TestingVincristineCord Blood Stem Cell TransplantationPrognosisNeoplasm, ResidualFollow-Up StudiesThiotepaImmunosuppressive AgentsBone Marrow PurgingMesenchymal Stem Cell TransplantationTime FactorsAntigens, CD34Myelodysplastic SyndromesLeukemiaLymphocyte TransfusionAntineoplastic AgentsAntibodies, Monoclonal, Murine-DerivedLymphoma, Mantle-CellCell TransplantationAmyloidosisLymphoma, FollicularHistocompatibilityGranulocyte Colony-Stimulating FactorSiblingsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveKidney TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaCytomegalovirus InfectionsDoxorubicinEmbryonic Stem CellsDexamethasoneBoronic AcidsLymphocyte DepletionAntilymphocyte SerumLymphomaAntineoplastic Agents, AlkylatingPyrazinesMinor Histocompatibility AntigensHepatic Veno-Occlusive DiseaseT-LymphocytesAdult Stem CellsChimerismAcute DiseaseThalidomideLeukapheresisVirus ActivationLeukemia, MyeloidAutograftsLymphoma, T-Cell, PeripheralIfosfamideHLA AntigensHematologic DiseasesProspective StudiesTransplantation ImmunologyPrednisoneFatal OutcomeInduction ChemotherapyAntibodies, MonoclonalCell Differentiation